Aethlon Medical (AEMD) Net Cash Flow (2010 - 2026)

Aethlon Medical's Net Cash Flow history runs 17 years deep, the most recent figure standing at -$1.9 million for Q1 2026.

• Quarterly Net Cash Flow fell 383.03% year-over-year to -$1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.6 million (down 22.77% YoY) and the FY2026 annual result came in at -$480192.0, down 686.66% from the prior year.
• Net Cash Flow was -$1.9 million for Q1 2026 at Aethlon Medical, down from $4.9 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $5.4 million in Q3 2025 and bottomed at -$3.3 million in Q1 2022.
• A 5-year average of $10177.9 and a median of -$1.7 million in 2025 frame the typical range for Net Cash Flow.
• Annual changes were most pronounced in 2022 — Net Cash Flow soared 340.52% — and 2026, when it tumbled 383.03%.
• Aethlon Medical's Net Cash Flow stood at -$2.1 million in 2022, then decreased by 4.99% to -$2.2 million in 2023, then surged by 190.6% to $2.0 million in 2024, then soared by 142.82% to $4.9 million in 2025, then slumped by 140.1% to -$1.9 million in 2026.
• Business Quant data shows AEMD's Net Cash Flow at -$1.9 million in Q1 2026, $4.9 million in Q4 2025, and $5.4 million in Q3 2025.